Amgen Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (102)

Latest Posts

About This Stock More About This Stock
Dow 30 Stock Roundup: Walmart, Cisco, Home Depot Beat On Earnings
Article By: Swarup Gupta
Friday, May 18, 2018 7:42 PM EDT
The Dow snapped a record streak of wins to traverse a turbulent week. Trade-war related concerns continued to weigh on investors with President Trump expressing doubts over the success of upcoming negotiations with China.
In this article: BRK-B, GE, HD, JNJ, JPM, M, PFE, WMT, AAPL, AMGN, CSCO
Read
Trump Announces Plan To Reign In Drug Prices And Pharma Stocks Rally
Article By: Zacks Investment Research
Sunday, May 13, 2018 11:37 AM EDT
President Trump unveiled his plan to control US drug prices. Stock prices of the biggest drug companies briefly declined, only to reverse course and ended the day broadly higher. The reason? The plan doesn’t seem to be “taking them on” at all.
In this article: LLY, MRK, AMGN, EXEL, ABBV
Read
Spectrum (SPPI) Earnings And Sales Beat Estimates In Q1
Article By: Zacks Investment Research
Saturday, May 5, 2018 9:05 PM EDT
Spectrum Pharma’s shares have underperformed the industry so far this year. The stock has lost 16.5% against the industry’s decline of 5%. Plus more news on Amgen, Ligand Pharmaceuticals and Protagonist Therapeutics.
In this article: SPPI, AMGN, LGND, PTGX
Read
Stocks Going Ex Dividend In May 2018
Article By: Fred Fuld
Sunday, April 29, 2018 4:44 PM EDT
Here is our latest update on the stock trading technique called ‘Buying Dividends'. This involves buying stocks before the ex dividend date and selling the stock after the ex date at about the same price, yet still being entitled to the dividend.
In this article: AFL, BAC, C, GS, GSK, IBM, LMT, TGT, V, WFC, XOM, AMGN, CAKE, INTC
Read
2018 Biotech Sector Watch On Earnings: AMGN, BIIB
Article By: Rod Raynovich
Wednesday, April 25, 2018 5:17 AM EDT
Stocks sell-off despite good earnings, healthcare (XLV​) down only 0.75%, 2.18% YTD.
In this article: BIIB, AMGN, IBB, XLV Also: RGEN, CELG, BMY, ALXN, VRTX, ABBV
Read

PARTNER HEADLINES

Latest Tweets for $AMGN

No tweets yet!

$AMGN

July 2017 Stock Considerations
Dick Kaplan 7/3/2017 3:14:44 AM

I read that #Repatha sales for this quarter are down significantly so be careful with $AMGN.

1 to 1 of 1 comments